Integra LifeSciences Holdings Corporation (NASDAQ:IART) is expected to report second quarter earnings results, after market close, on Monday 10th August 2020.
Analysts polled by Thomson Reuters anticipate second quarter income of $ 0.10 per share.
Looking ahead, the full year income are expected at $ 1.86 per share on the revenues of $ 1315.05 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,550.00 million ~ $ 1,570.00 million, where as bottomline are predicted in a range of $ 3.00 ~ $ 3.05 per share
Click Here For More Historical Outlooks Of Integra LifeSciences Holdings Corporation
Previous Quarter Performance
Integra LifeSciences Holdings Corporation announced income for the first quarter of $ 0.48 per share, from the revenue of $ 354.32 million. The quarterly earnings reduced 26.15 percent while revenues shrunk 1.49 percent compared with the same quarter last year.
Street analysts expected Integra LifeSciences Holdings Corporation to report income of $ 0.64 per share on revenue of $ 363.24 million for the first quarter. The bottom line results missed street analysts by $ 0.16 or 25 percent, at the same time, top line results fell short of analysts by $ 8.92 million or 2.46 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Integra LifeSciences Holdings Corporation
Stock Performance
According to the previous trading day, closing price of IART was $ 48.09, representing a 40.57 % increase from the 52 week low of $ 34.21 and a 25.14 % decrease over the 52 week high of $ 64.24.
The company has a market capital of $ 4.08 billion and is part of the Healthcare sector and Medical Devices industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”IART” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
Integra LifeSciences Holdings Corporation will be hosting a conference call at 4:30 PM eastern time on 10th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.integralife.com
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. It offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.
